Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?
Saved in:
| Published in: | Metalloproteinases In Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2016
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?
- Nonproteolytic functions of matrix metalloproteinases in pathology and insights for the development of novel therapeutic inhibitors
- Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives
- Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine
- Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine
- Matrix metalloproteinases in cystic fibrosis: pathophysiologic and therapeutic perspectives
- Matrix metalloproteinases and their inhibitors in cardiovascular pathologies: current knowledge and clinical potential